Molecular targeted therapy of gastric cancer; recent progress / 第二军医大学学报
Academic Journal of Second Military Medical University
;
(12): 305-311, 2014.
Article
in Chinese
| WPRIM
| ID: wpr-839102
ABSTRACT
Despite chemotherapy regimens foradvanced gastric cancer keep emerging, the patients stillhave poor prognosis. Molecular targeted therapy is another important direction for the treatment of advanced gastric cancer. Various drugs for molecular targeted therapy have been developed targeting epidermal growth factor receptor (EGFR), human epidermal growth factor receptor-2 (HER-2), vascular endothelial growth factor (VEGF) and its receptor (VEGFR), and cyclooxygenase-2 (COX-2); a number of II /W clinical trial have been completed or being conducted. The aim of this review is to summarize the recent progress on molecular targeted therapy for gastric cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Academic Journal of Second Military Medical University
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS